Table 2 Logistic regression analysis of the pre-treatment variables associated with poor prognosis of extraocular muscle movement limitation in the restrictive myopathy associated with thyroid eye disease.
From: Prognostic factors of restrictive myopathy in thyroid eye disease
Parameters | Univariate analysis | Multivariate analysis | ||||
|---|---|---|---|---|---|---|
OR | 95% CI | P | OR | 95% CI | P* | |
Age, years | 0.99 | 0.94–1.04 | 0.614 | 0.91 | 0.81–1.03 | 0.138 |
Sex, M:F | 0.94 | 0.36–2.51 | 0.909 | 0.55 | 0.30–9.94 | 0.546 |
Disease onset, mo | 1.11 | 0.95–1.31 | 0.191 | 1.01 | 0.74–1.37 | 0.953 |
CAS | 0.91 | 0.68–1.22 | 0.540 | |||
Diplopia grade | 1.12 | 0.66–1.90 | 0.681 | |||
TSH, μIU/mL | 0.99 | 0.91–1.08 | 0.89 | |||
T3, ng/dL | 1.01 | 0.99–1.02 | 0.483 | |||
fT4, ng/dL | 0.61 | 0.25–1.45 | 0.259 | 0.19 | 0.03–1.18 | 0.075 |
TSAb, 10% | 1.06 | 1.01–1.11 | 0.028 | 1.09 | 1.00–1.18 | 0.044 |
TSHR-Ab, 10 IU/L | 1.00 | 0.89–1.14 | 0.975 | |||
Treatment, n | ||||||
Conservative | 0.97 | 0.13–7.32 | 0.975 | |||
Oral PD | 0.96 | 0.34–2.67 | 0.929 | |||
IV methylPD | 0.43 | 0.13–1.43 | 0.166 | 0.80 | 0.11–5.81 | 0.827 |
Radiotherapy | 1.09 | 0.39–3.02 | 0.867 | |||
